By interacting with PD-1 receptors on the surface of T cells, PD-L1 on the surface of tumor cells can induce the death of activated T cells and boost IL-10 production in human peripheral blood, thereby promoting immunosuppression and tumor progression 5. This evidence concerns the gene IL10 and neoplasm.